NYMC Faculty Publications
Award
NYMC First Author of a research article published in a journal with the highest impact factor at the 2019 NYMC Faculty Author Celebration
Journal Title
Nature Communications
First Page
2329
Document Type
Article
Publication Date
6-1-2018
Department
Pathology, Microbiology and Immunology
Abstract
The ubiquitin regulatory X domain-containing proteins (UBXNs) are likely involved in diverse biological processes. Their physiological functions, however, remain largely unknown. Here we present physiological evidence that UBXN3B positively regulates stimulator-of-interferon genes (STING) signaling. We employ a tamoxifen-inducible Cre-LoxP approach to generate systemic Ubxn3b knockout in adult mice as the Ubxn3b-null mutation is embryonically lethal. Ubxn3b(-/-), like Sting(-/-) mice, are highly susceptible to lethal herpes simplex virus 1 (HSV-1) and vesicular stomatitis virus (VSV) infection, which is correlated with deficient immune responses when compared to Ubxn3b(+/+) littermates. HSV-1 and STING agonist-induced immune responses are also reduced in several mouse and human Ubxn3b(-/-) primary cells. Mechanistic studies demonstrate that UBXN3B interacts with both STING and its E3 ligase TRIM56, and facilitates STING ubiquitination, dimerization, trafficking, and consequent recruitment and phosphorylation of TBK1. These results provide physiological evidence that links the UBXN family with antiviral immune responses.
Recommended Citation
Yang, L., Wang, L., Ketkar, H., Ma, J., Yang, G., Mordue, D., & Wang, P. (2018). UBXN3B Positively Regulates STING-Mediated Antiviral Immune Responses. Nature Communications, 9 (1), 2329. https://doi.org/10.1038/s41467-018-04759-8
Publisher's Statement
Originally published in Nature Communications, 9(1), 2329]. The original material can be found here.
Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.
Comments
Please see the work itself for the complete list of authors.